RE: or it could bounce from here...6 Nov 2018 11:53
Marineville true thats been the difference you have traded well since june this year, in my case I had to get in after July's crash as I accepted there was a business case to close the reformulation section and concentrate on Nuvec this should speed up strategy to seek out partners to evaluate Nuvec within their products, having already signed one with MedImmune UK.,trip to Japan was successful in sounding out potential partners feel the Company's strategy allows it to determine precisely how Nuvec will be used by its partners, either as a vaccine, a delivery system for therapeutics. This is the basis of my long term investment IMO however DYOR I have done mine to put my kitchen sink and my roof in here...hah! hah!